Ilyas Sahin, Medical Oncologist at Massachusetts General Hospital, shared on X:
“Should cancer patients on immunotherapy get the COVID mRNA vaccine?
New French study Annals of Oncology, 30,898 patients: yes. 9% lower risk of death when given within 3 months of starting a PD-(L)1 inhibitor.
Consistent across lung, melanoma, head and neck, kidney. Smaller than the Nature paper (2025), but tighter methodology and 30x more patients.”
Other articles featuring Ilyas Sahin on OncoDaily.